Assembly Biosciences, Inc.
ASMB
$32.87
-$2.41-6.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.86M | -9.08M | 22.09M | -9.20M | -10.20M |
| Total Depreciation and Amortization | 20.00K | 26.00K | 32.00K | 32.00K | 32.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.85M | 531.00K | 834.00K | 1.25M | 674.00K |
| Change in Net Operating Assets | -13.50M | -13.58M | -8.72M | -7.22M | -7.27M |
| Cash from Operations | -15.49M | -22.10M | 14.24M | -15.13M | -16.76M |
| Capital Expenditure | 0.00 | -19.00K | -24.00K | -42.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -92.08M | -5.36M | 21.25M | -158.23M | 16.99M |
| Cash from Investing | -92.08M | -5.38M | 21.22M | -158.27M | 16.99M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 108.74M | 149.00K | 456.00K | 171.93M | 357.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 108.74M | 149.00K | 456.00K | 171.93M | 357.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.17M | -27.33M | 35.92M | -1.47M | 593.00K |